Drug · DIN 02542307
EPKINLY
SINGLE-USE VIAL
Yes: authorized and sold in Canada
Authorized, and the company reports that it sells it in Canada.
Status Marketed since December 18, 2023; first marketed December 18, 2023.
- Drug Identification Number (DIN)
- 02542307
- Company (DIN owner)
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Schedule
- Schedule D; Prescription
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Epcoritamab L01FX27
- Class
- Human
- Record last updated
- September 21, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EPCORITAMAB | 60 MG | ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 13, 2023: NOC 31861New Drug Submission (NDS)
Other DINs named EPKINLY
- DIN 02542293 · Marketed